Park Joon-Kee, Yang Shin-Seok, Kim Dong-Ik, Kim Young-Wook, Kim Da-Hyun, Park Yang-Jin
Division of Vascular Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Division of Vascular Surgery, Department of Surgery, Incheon Sejong Hospital, Incheon, Korea.
Ann Surg Treat Res. 2024 May;106(5):248-254. doi: 10.4174/astr.2024.106.5.248. Epub 2024 Apr 30.
This study was performed to analyze the association between age and outcomes of carotid endarterectomy (CEA) by comparing postoperative outcomes between octogenarians and younger patients.
From November 1994 to December 2022, 1,585 internal carotid arteries of 1,434 patients were enrolled. Patients were stratified into 2 groups: octogenarians (≥80 years old) and non-octogenarians (<80 years old). Primary endpoints were early (≤30 days) outcomes of ipsilateral stroke, any stroke, myocardial infarction, death, and major adverse cardiovascular events (MACE). We also compared overall any stroke and death between the 2 groups.
One of 132 octogenarians (0.8%) and 17 of 1,453 non-octogenarians (1.1%) experienced ipsilateral stroke within 30 days. Thirty-day MACE occurred in 4 of 132 octogenarians (3%) and 44 of 1,453 non-octogenarians (3%). There were no significant differences in any early (≤30 days) outcomes. Symptomatic status was associated with increased 30-day MACE (odds ratio [OR], 2.610; 95% confidence interval [CI], 1.450-4.696; P = 0.003) and 30-day any stroke (OR, 3.999; 95% CI, 1.627-9.828; P = 0.003). Symptomatic status was also associated with overall any stroke (hazard ratio [HR], 2.885; 95% CI, 1.865-4.463; P < 0.001), but age of ≥80 years was not associated with 30-day MACE, 30-day any stroke, or overall stroke. Age of ≥80 years was only associated with overall survival (HR, 2.644; 95% CI, 1.967-3.555; P < 0.001).
CEA would be a safe and effective treatment for octogenarians with low 30-day complications and long-term stroke rates, comparable with that of younger counterparts. Advanced age is not a contraindication for CEA.
本研究旨在通过比较八旬老人与年轻患者的术后结局,分析年龄与颈动脉内膜切除术(CEA)结局之间的关联。
从1994年11月至2022年12月,纳入1434例患者的1585条颈内动脉。患者被分为两组:八旬老人(≥80岁)和非八旬老人(<80岁)。主要终点是同侧卒中、任何卒中、心肌梗死、死亡和主要不良心血管事件(MACE)的早期(≤30天)结局。我们还比较了两组之间总体任何卒中及死亡情况。
132例八旬老人中有1例(0.8%),1453例非八旬老人中有17例(1.1%)在30天内发生同侧卒中。132例八旬老人中有4例(3%)发生30天MACE,1453例非八旬老人中有44例(3%)发生30天MACE。任何早期(≤30天)结局均无显著差异。症状状态与30天MACE增加相关(比值比[OR],2.610;95%置信区间[CI],1.450 - 4.696;P = 0.003)以及30天任何卒中相关(OR,3.999;95% CI,1.627 - 9.828;P = 0.003)。症状状态也与总体任何卒中相关(风险比[HR],2.885;95% CI,1.865 - 4.463;P < 0.001),但≥80岁与30天MACE、30天任何卒中或总体卒中无关。≥80岁仅与总体生存率相关(HR,2.644;95% CI,1.967 - 3.555;P < 0.001)。
CEA对于八旬老人是一种安全有效的治疗方法,30天并发症发生率和长期卒中率较低,与年轻患者相当。高龄并非CEA的禁忌证。